🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
MIR
$MIRM
🔒 US EquitiesMirum Pharmaceuticals Inc
AVG HISTORICAL GAP
-1.28%
MAX GAP RECORD
-14.69%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $MIRM
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$MIRM
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Nov 04, 2026 Earnings Release 2026-11-04 (AFTER CLOSE (21:00)) | 🔮 UPCOMING 🔒 |
| Aug 05, 2026 Earnings Release 2026-08-05 (AFTER CLOSE) |
-14.69%
|
| May 06, 2026 Earnings Release 2026-05-06 (AFTER CLOSE) |
+0.00%
|
| Feb 25, 2026 Earnings Release 2026-02-25 (AFTER CLOSE) |
-11.13%
|
| Nov 04, 2025 Earnings Release 2025-11-04 (AFTER CLOSE) |
+3.47%
|
| Aug 06, 2025 Earnings Release 2025-08-06 (AFTER CLOSE) |
+3.48%
|
| May 07, 2025 Earnings Release 2025-05-07 (AFTER CLOSE) |
-2.96%
|
| Feb 26, 2025 Earnings Release 2025-02-26 (AFTER CLOSE) |
-3.01%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
4.5%
Bullish Gaps (5)
Bearish Gaps (6)
Neutral / Flat (2)
📖 Intelligence Summary
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company. The firm focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. Its products pipeline includes Maralixibat, Cholbam, Ctexli, Volixibat, Brelovitug, MRM-3379, and Zilurgisertib. The company was founded by Niall O'Donnel, Michael G. Grey, and Christopher…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗